Boston, MA 06/13/2013 (wallstreetpr) – The share prices of Echo Therapeutics Inc (NASDAQ:ECTE) had been traded in the price range of $3.25 and $3.80 on Wednesday. The company’s share price had had gradually decreased by 11.26 percentage less than the previous day. The opening price is $3.74, which is about to a net change of nearly $0.20. The share price of Echo Therapeutics Inc (NASDAQ:ECTE) had no effect in the 52 week high value $18.90 and 52 week low value $ 1.84. The net change by the end of Wednesday is decreased by 0.42. The market had been working after hours as the net change is increased by 0.01, when compare to the closing hours.
The company Echo Therapeutics Inc (NASDAQ:ECTE) is primarily involved in manufacture, marketing and sales of transdermal medical devices. It is based on the technology to provide for painless and skin permeation which is processed through both needle free drug delivery and analytic extraction.
The company had recently submitted the package for symphony CGM system being developed by the company for approval and submission from the Food and Drug Administration of United States for use in hospitals in critical care situations. They also requested for meeting with FDA to enable cooperative working of this product with a clinical and regulatory approval. This pre submission package is a milestone towards commercialization of the Symphony CMG system in the United States market, as the meeting will helps the company to produce more product with large numbers as the input.
The market capitalization value is about 209.39 million and institutional investors share’s percentage is about 1 only. The Echo Therapeutics Inc (NASDAQ:ECTC) been contain a trading volume as 388,863 and the average volume as 48,787 per day on Wednesday. The company presently holds 63.26 million shares outstanding in the market. The risk to investors with market or other economic reason is about 0.47.
